4.7 Review

Intervertebral Disc-on-a-Chip as Advanced In Vitro Model for Mechanobiology Research and Drug Testing: A Review and Perspective

Journal

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fbioe.2021.826867

Keywords

intervertebral disc; mechanical loading; microphysiological device design; organ-on-a-chip; mechanobiology; degenerative disc disease (DDD)

Funding

  1. Center for Applied Biotechnology and Molecular Medicine (CABMM)
  2. European Union [841975]
  3. Swiss National Science Foundation [P2EZP2_199914]
  4. Swiss National Science Foundation (SNF) [P2EZP2_199914] Funding Source: Swiss National Science Foundation (SNF)
  5. Marie Curie Actions (MSCA) [841975] Funding Source: Marie Curie Actions (MSCA)

Ask authors/readers for more resources

Discogenic back pain is a common pathology that affects the quality of life for millions of people. Current treatments focus on symptom reduction rather than targeting the underlying degenerative processes. Existing disease models do not fully replicate the course of degenerative disc disease. Organs-on-chip (OoC) platforms are microfluidic devices that aim to replicate tissue functions and investigate pathological alterations. They have the potential to mimic physiological or aberrant mechanical loading in intervertebral discs.
Discogenic back pain is one of the most diffused musculoskeletal pathologies and a hurdle to a good quality of life for millions of people. Existing therapeutic options are exclusively directed at reducing symptoms, not at targeting the underlying, still poorly understood, degenerative processes. Common intervertebral disc (IVD) disease models still do not fully replicate the course of degenerative IVD disease. Advanced disease models that incorporate mechanical loading are needed to investigate pathological causes and processes, as well as to identify therapeutic targets. Organs-on-chip (OoC) are microfluidic-based devices that aim at recapitulating tissue functions in vitro by introducing key features of the tissue microenvironment (e.g., 3D architecture, soluble signals and mechanical conditioning). In this review we analyze and depict existing OoC platforms used to investigate pathological alterations of IVD cells/tissues and discuss their benefits and limitations. Starting from the consideration that mechanobiology plays a pivotal role in both IVD homeostasis and degeneration, we then focus on OoC settings enabling to recapitulate physiological or aberrant mechanical loading, in conjunction with other relevant features (such as inflammation). Finally, we propose our view on design criteria for IVD-on-a-chip systems, offering a future perspective to model IVD mechanobiology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available